Lymphocye subsets in tumour patients during subcutaneous mistletoe therapy;Entwicklung lymphozytärer subpopulationen bei tumorpatienten nach subkutaner applikation von mistelextrakten

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 6, Issue 4, 1999, Pages 196-204

  Bussing A ^a,c   Rosenberger, A ^b   Stumpf, C ^a   Schietzel, M ^a  

^a Gemeinschaftskrankenhaus Herdecke   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Krebsforschung Herdecke   (Germany)

Author keywords

Lymphocyte subsets; Mistletoe therapy; Tumour patients

Indexed keywords

PLANT EXTRACT; CD19 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MEDICINAL PLANT; MIDDLE AGED; NEOPLASM; PHYTOTHERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; VISCUM ALBUM; B LYMPHOCYTE; CLINICAL ARTICLE; HELPER CELL; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NATURAL KILLER CELL; SUPPRESSOR CELL; TUMOR;

ADULT; AGED; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MISTLETOE; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; T-LYMPHOCYTE SUBSETS;

EID: 0032589597     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bussing A: Induction of apoptosis by the mistletoe lectins. A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1996;1:25-32.
2. Bussing A: Apoptose-Induktion und DNA-Stabilisierung durch Viscum album L. Forsch Komplementärmed 1998;5:164-171.
3. Bussing A, Wagner M, Wagner B, Stein GM, Schietzel M, Schaller G, Pfüller U: Induction of mitochondrial Apo2.7 molecules and generation of reactive oxygen-intermediates in cultured lymphocytes by the toxic proteins from Viscum album L. Cancer Lett 1999;139:79-88.
4. Büssing A, Stein GM, Wagner M, Wagner B, Schaller G, Pfüller U, Schietzel M: Accidental cell death and generation of reactive oxygen intermediates in human lymphocytes induced by thionins from Viscum album L. Eur J Biochem 1999;262:79-87.
5. Seeger PAG: Über die Wirkung von Mistelextrakten [Iscador und Plenosol] auf die Vitalität und Verimpfbarkeit von Tumorzellen des Ehrlichschen Ascitescarcinoms der Maus, zugleich ein Beitrag zur Bedeutung der lymphocytären Geschwulstabwehr als erfolgreichstem Wirkungsfaktor von Viscumextrakten. Erfahrungsheilkunde 1965;14:149-174, 253-272, 301-317.
6. Bloksma N, van Dijk H, Korst P, Willers JM: Cellular and humoral adjuvant activity of a mistletoe extract. Immunobiology 1979;156:309-319.
7. Bloksma N, Schmiermann P, de Reuver M, van Dijk H, Willers JM: Stimulation of humoral and cellular immunity by Viscum preparations. Planta Med 1982;4:221-227.
8. Nienhaus J, Leroi R: Tumorhemmung und Thymusstimulation durch Mistelpräparate. Elem Naturwiss 1970;13:45-54.
9. Nienhaus J, Stoll M, Vester F: Thymus stimulation and cancer prophylaxis by Viscum proteins. Experientia 1970;26:523-525.
10. Bussing A, Fischer K, Schietzel M: Misteltherapie und immunologische Forschung. Forsch Komplementärmed 1996;3(suppl 1):1-24.
11. Beuth J, Ko HL, Gabius HJ, Burrichter H, Oette K, Pulverer G: Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 1991;70:658-661.
12. Beuth J, Ko HL, Gabius HJ, Pulverer G: Influence of treatment with the immunomodulatory effective dose of β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. In Vivo 1991;5:29-32.
13. Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G: Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. In Vivo 1993;7:407-410.
14. Beuth J, Ko HL, Tunggal L, Geisel J, Pulverer G: Vergleichende Untersuchungen zur immunaktiven Wirkung von Galaktosid-spezifischem Mistellektin. Reinsubstanz gegen standardisiertem Extrakt. Arzneimittelforschung 1993;43:166-169
15. Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G: Immunaktive Wirkung von Mistellektin-1 in Abhängigkeit von der Dosierung. Arzneimittelforschung 1994;44: 1255-1258.
16. Beuth J, Stiffel B, Ko HL, Jeljaszewicz J, Pulverer G: Immunomodulatory ability of galactoside-specific lectin standardized and depleted mistletoe extract. Arzneimittelforschung 1995;45:1240-1242.
17. Beuth J, Stoffel B, Samtleben R, Staak O, Ko HL, Pulverer G, Wagner H: Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c mice. Phytomedicine 1996;2: 239-273.
18. Beuth J: Clinical relevance of immunoactive mistletoe lectin-1. Anticancer Drugs 1997; 8(suppl 1):S53-S55.
19. Hajto T: Immunomodulatory effects of iscador: A Viscum album preparation. Oncology 1986; 43(suppl 1):51-65.
20. Hajto T, Hostanska K, Gabius W: Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989;49:4803-4808.
21. Hajto T, Hostanska K, Frey K, Rordorf C, Gabius HJ: Increased secretion of tumor necrosis factor d, interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990;50:3322-3326.
22. Hajto T, Hostanska K, Fischer J, Lentzen H: Investigations of cellular parameters to establish the response of a biomodulator: Galactoside-specific lectin from Viscum album plant extract. Phytomedicine 1996;3:129-137.
23. Heiny BM, Beuth J: Misteltoe extract standardized for the galactoside-specific lectin (ML-1) induces β-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994;14:1339-1342.
24. Khwaja TA, Varven JC, Pentecost S, Pande H: Isolation and biologically active alkaloids from Korean misteltoe, Viscum album, coloratum. Experientia 1980;36:599-560.
25. Khwaja TA, Dias CB, Papoian T, Pentecost S: Studies on cytotoxic and immunologic effects of Viscum album (mistletoe). Proc. Am. Ass. Cancer Res. 1980;22:253.
26. Khwaja TA, Dias CB, Pentecost S: Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 1986;43(suppl 1):42-50.
27. Müller EA, Anderer FA: Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: Chemical specificity of target cell recognition. Cancer Res 1990;50:3646-3651.
28. Müller EA, Anderer FA: A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer. Cancer Immunol Immunother 1990;32:221-227.
29. Müller EA, Anderer FA: Chemical specificity of effector/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells. Immunopharmacology 1990;19: 69-77.
30. Zhu HG, Zollner TM, Klein-Franke A, Anderer FA: Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: Target cell specificity and activity against NK-insensitive targets. J Cancer Res Clin Oncol 1994;120:383-388.
31. Kuttan G, Vasudevan DM, Kuttan R: Isolation and identification of a tumour reducing component from mistletoe extract (Iscador). Cancer Lett 1988;41:307-314.
32. Kuttan G, Vasuddevan DM, Kuttan R: Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol 1990;29:35-41.
33. Kuttan G, Vasudevan DM, Kuttan R: Tumour reducing activity of an isolated active ingredient from mistletoe extract and its possible mechanism of action. J Exp Clin Cancer Res 1992;11:7-12.
34. Kuttan G, Kuttan R: Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NSC 635 089) cellular proliferation. Cancer Lett 1992;66:123-130.
35. Kuttan G, Kuttan R: Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest 1992;21:285-296.
36. Fischer S, Scheffler A, Kabelitz D: Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 1997;8(suppl 1):S33-S37.a
37. Fischer S, Scheffler A, Kabelitz D: Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe treated cancer patients. Cancer Immunol Immunother 1997;44: 150-156.
38. Stein GM, Schaller G, Pfüller U, Wagner M, Wagner B, Schietzel M, Bussing A: Characterisation of granulocyte stimulation by thionins from European mistletoe and from wheat. Biochim Biophys Acta 1998;24730:80-90.
39. Stein GM, Berg PA: Non-lectin component in a fermented extract from Viscum album L. grown on pines induced proliferation of lymphocytes from healthy and allergic individuals in vitro. Eur J Clin Pharmacol 1994;47:33-38.
40. Stein GM, Schaller G, Pfüller U, Schietzel M, Bussing A: Thionins from Viscum album L.: influence of viscotoxins on the activation of granulocytes. Anticancer Res 1999;19:1037-1042.
41. Stein GM, Berg PA: Evaluation of the stimulatory activity of a fermented mistletoe lectin I-free mistletoe extract on T-helper cells and monocytes in healthy individuals in vitro. Arzneimittelforschung 1996;46:635-639.
42. Schink M: Mistletoe therapy for human cancer: The role of the natural killer cells. Anticancer Drugs 1997;8(suppl 1):S47-S51.
43. Stein GM, Stettin A, Schultze J, Berg PA: Induction of anti-mistletoe lectin antibodies in relation to different mistletoe extracts. A short review. Anticancer Drugs 1997;8(suppl 1):S57-S59.
44. Stein GM, Schietzel M, Bussing A: Mistletoe in immunology and the clinic (short review). Anticancer Res 1998;18:3247-3257.
45. Stein GM, Kenn W, von Laue HB, Berg PA: Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur J Med Res 1998;3:194-202.
46. Stein GM, Berg PA: Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract. Eur J Med Res 1998;3:307-314.
47. Kubasova T, Pfüller U, Köteles GJ: Changes in cytotoxic ability and cytokine release of human leukocytes upon the effect of mistletoe lectin in vitro; in Bardocz S, Pusztai A (eds): COST 98. Effects of Antinutrients on the Nutritional Value of Legume Diets, Vol. 2. Luxembourg, Office for Official Publications of the European Communites, 1996, pp 17-23.
48. Ribéreau-Gayon G, Dumont S, Müller C, Jung ML, Poindron P, Anton R: Mistletoe lectins I, II, and III induce the production of cytokines by cultured human monocytes. Cancer Lett 1996;109:33-38.
49. Lenartz D, Stoffel B, Menzel J, Beuth J: Immunoprotective activity of galactoside-specific lectin from mistletoe after tumour destructive therapy in glioma patients. Anticancer Res 1996;16:3799-3802.
50. Bussing A, Suzart K, Schweizer K, Schietzel M: Killing und Inflammation - Über die Apoptoseinduzierende Potenz von Viscum album L.-Extrakten. Z Onkol 1996;28:2-9.